Acromegaly Completed Phase 2 Trials for Lanreotide (DB06791)

Also known as: Acromegalic / Acromegaly (disorder)

Indication	Status	Phase
DBCOND0000951 (Acromegaly)	Completed	2

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT03967249	Extension Study of IONIS-GHR-LRx Administered to Participants With Acromegaly Being Treated With Long-acting Somatostatin Receptor Ligands	Treatment	Lanreotide (DB06791) Octreotide (DB00104) Somatostatin (DB09099)